Key result
Intracerebroventricular infusion of aldosterone significantly increased blood pressure, heart rate, and oxidative stress in rats, which was prevented by Digibind or benzamil.
Aldosterone centrally activates the renin-angiotensin system and oxidative stress via an 'ouabain'-dependent pathway, providing mechanistic insight into salt-sensitive hypertension and post-MI heart failure.
Central aldosterone may drive PVN changes in hypertensive and post-MI rats; leaves open translation to human disease.
In rats with salt-induced hypertension or postmyocardial infarction, angiotensin II type 1 receptor (AT(1)R) densities and oxidative stress increase and neuronal NO synthase (nNOS) levels decrease in the paraventricular nucleus (PVN). The present study was designed to determine whether these changes may depend on activation of the aldosterone -'ouabain' neuromodulatory pathway. After intracerebroventricular (i.c.v.) infusion of aldosterone (20 ng h(-1)) for 14 days, blood pressure (BP) and heart rate (HR) were recorded in conscious Wistar rats, and mRNA and protein for nNOS, endothelial NO synthase (eNOS), AT(1)R and NADPH oxidase subunits were assessed in brain tissue. Blood pressure and HR were significantly increased by aldosterone. Aldosterone significantly increased mRNA and protein of AT(1)R, P22phox, P47phox, P67phox and Nox2, and decreased nNOS but not eNOS mRNA and protein in the PVN, as well as increased the angiotensin-converting enzyme and AT(1)R binding densities in the PVN and supraoptic nucleus. The increases in BP and HR, as well as the changes in mRNA, proteins and angiotensin-converting enzyme and AT(1)R binding densities were all largely prevented by concomitant i.c.v. infusion of Digibind (to bind 'ouabain') or benzamil (to block presumed epithelial sodium channels). These data indicate that aldosterone, via 'ouabain', increases in the PVN angiotensin-converting enzyme, AT(1)R and oxidative stress, but decreases nNOS, and suggest that endogenous aldosterone may cause the similar pattern of changes observed in salt-sensitive hypertension and heart failure postmyocardial infarction.
No takes yet. Share an insight, caveat, or question.
Huang et al. (2011) studied Hypertension and postmyocardial infarction models. Intracerebroventricular infusion of aldosterone vs. Concomitant infusion of Digibind or benzamil was evaluated on Blood pressure, heart rate, and brain tissue mRNA/protein levels of nNOS, eNOS, AT(1)R and NADPH oxidase subunits. Intracerebroventricular infusion of aldosterone significantly increased blood pressure, heart rate, and oxidative stress in rats, which was prevented by Digibind or benzamil.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: